.INVESTIGATION FEATURE.06 August 2024.
A big randomized regulated test with cisgender ladies highlights the challenges of faithfulness to a daily dental preexposure treatment program and illustrates that twice-yearly treatment of lenacapavir may sustain helpful HIV deterrence amounts over 6 months.